D25.9
Leiomyoma of uterus, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Leiomyoma of the uterus, also known as uterine fibroids, are non-cancerous growths that develop within the muscular wall of the uterus. The medical classification for this condition is ICD-10 Code D25.9, indicating an unspecified type of uterine fibroid. These tumors are common among women of reproductive age and can vary significantly in size, number, and location within the uterus. Though many women with fibroids experience no symptoms, others may face various health issues that can impact their quality of life. Understanding the causes, symptoms, diagnosis, and possible treatments can help women manage this condition more effectively.
Causes & Symptoms
Clinical Causes: Genetic factors: Family history can increase susceptibility. Hormonal influences: Estrogen and progesterone levels can promote fibroid growth. Age: The likelihood of developing fibroids increases with age, especially during reproductive years. Previous pregnancies: Paradoxically, pregnancy can influence fibroid growth in various ways. Obesity: Excess body weight may be linked to increased fibroid risk. Diet and lifestyle: High consumption of red meat and low intake of fruits and vegetables may be contributing factors. Other factors: Ethnicity, with higher prevalence noted in African American women.
Key Symptoms: Heavy menstrual bleeding (menorrhagia) Prolonged period duration Pelvic pain or pressure Frequent urination due to pressure on the bladder Constipation or difficulty with bowel movements Backache or leg pain Enlarged abdomen or feeling of fullness Pain during sexual intercourse (dyspareunia)
Diagnostic & Treatment
Diagnosis Path: Ultrasound: The most common imaging technique to identify fibroids and assess their size and number. MRI (Magnetic Resonance Imaging): Provides detailed images, especially useful for complex cases or planning surgery. Hysterosonography: Saline infusion sonography that enhances visualization of the uterine cavity. Hysterosalpingography: X-ray with contrast that can reveal the presence of submucosal fibroids. Hysteroscopy: A direct visual examination of the uterine cavity using a thin, lighted instrument.
Treatment Protocols: Watchful waiting: For women with mild or no symptoms, regular monitoring may be recommended. Medications: To manage symptoms, including hormonal therapies like GnRH agonists, oral contraceptives, or tranexamic acid to control bleeding. Non-invasive procedures: MRI-guided focused ultrasound therapy to destroy fibroid tissue. Minimally invasive techniques: Uterine artery embolization to reduce blood flow and shrink fibroids, or laparoscopic myomectomy to remove fibroids while preserving the uterus. Surgical options: Myomectomy for removal of fibroids, or hysterectomy for complete removal of the uterus, usually considered in severe or unresponsive cases.
Clinical Advice & FAQs
Billing Guidance
Is D25.9 a billable ICD-10 code?
Yes, D25.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D25.9?
Clinical documentation must specify the nature of Leiomyoma of uterus, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference